Lipid Forum-3
|
10:00-12:00
|
|---|
| 主席 Chairman | 王建安 Jianan WANG | ||
| 主持 Moderators | 刘斌 Bin LIU, 王焱 Yan WANG, 高传玉 Chuanyu GAO, 鄢华 Hua YAN | ||
|
10:00-10:05 |
大会主席致辞 Opening Remarks |
定 待 | |
|
10:05-10:25 |
ESC 2025热点聚焦：中国原研PCSK9i 助力血脂管理新方案 ESC 2025 Highlights: China's Indigenous PCSK9 Inhibitor Contributes to Novel Lipid-Management Strategies |
施仲伟 Zhongwei SHI | |
|
10:25-10:45 |
从单抗发展史看中国企业的创新与突破 Innovation and Breakthroughs of Chinese Enterprises: Perspectives from the Evolution of Monoclonal Antibodies |
史旭波 Xubo SHI | |
|
10:45-11:05 |
PCI术后高效血脂管理策略 Strategies for Efficient Lipid Management Post-Percutaneous Coronary Intervention |
陆峰 Feng LU | |
|
11:05-11:25 |
FLAVOUR IV：使用PCSK9抑制剂进一步降脂对冠状动脉CT血管造影提示的高危斑块的心血管结局影响 Further Lipid-Lowering with PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography |
胡新央 Xinyang HU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
周建华 Jianhua ZHOU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
于雪 Xue YU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
陈样新 Yangxin CHEN | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
曲新凯 Xinkai QU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
薛玉增 Yuzeng XUE | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
袁杰 Jie YUAN | |
|
11:55-12:00 |
总结 Summary |
定 待 | |